{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:30:24Z","timestamp":1791955824538,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002632","name":"Hallym University","doi-asserted-by":"publisher","award":["HURF-2015-08"],"award-info":[{"award-number":["HURF-2015-08"]}],"id":[{"id":"10.13039\/501100002632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002632","name":"Hallym University","doi-asserted-by":"publisher","award":["HURF-2016-40"],"award-info":[{"award-number":["HURF-2016-40"]}],"id":[{"id":"10.13039\/501100002632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2016R1D1A1B03935447"],"award-info":[{"award-number":["NRF-2016R1D1A1B03935447"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.prp.2017.01.004","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T09:32:11Z","timestamp":1484127131000},"page":"381-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers"],"prefix":"10.1016","volume":"213","author":[{"given":"Mi Jung","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang Yong","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sook","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Rim","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Kee","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwon","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyueng-Whan","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Young","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2017.01.004_bib0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00428-012-1358-0","article-title":"Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer","volume":"462","author":"Ach","year":"2013","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2017.01.004_bib0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2559.2002.00353.x","article-title":"c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma","volume":"40","author":"Aishima","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2017.01.004_bib0015","series-title":"Tumors of the Gallbladder, Extrahepatic Bile Ducts, and Ampulla of Vater","first-page":"259","article-title":"Malignant epithelial tumors of the ampulla","author":"Albores-Saavedra","year":"2000"},{"key":"10.1016\/j.prp.2017.01.004_bib0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0039-6060(05)80197-7","article-title":"Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival","volume":"117","author":"Allema","year":"1995","journal-title":"Surgery"},{"key":"10.1016\/j.prp.2017.01.004_bib0025","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/jso.21676","article-title":"Clinical value of plasma hepatocyte growth factor measurement for the diagnosis of periampullary cancer and prognosis after pancreaticoduodenectomy","volume":"102","author":"Barakat","year":"2010","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.prp.2017.01.004_bib0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejso.2008.01.030","article-title":"An audit of outcomes of a series of periampullary carcinomas","volume":"35","author":"Berberat","year":"2009","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.prp.2017.01.004_bib0035","series-title":"AJCC Cancer Staging Manual","first-page":"241","article-title":"Exocrine cancer endocrine pancreas","author":"A.J.C.o","year":"2010"},{"key":"10.1016\/j.prp.2017.01.004_bib0040","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1200\/JCO.2008.19.1635","article-title":"Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients","volume":"27","author":"Cappuzzo","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2017.01.004_bib0045","first-page":"889","article-title":"Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis","volume":"147","author":"Furukawa","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2017.01.004_bib0050","first-page":"13","article-title":"c-Met as a target for personalized therapy","volume":"7","author":"Garajova","year":"2015","journal-title":"Transl. Oncogenom."},{"key":"10.1016\/j.prp.2017.01.004_bib0055","first-page":"129","article-title":"K-ras mutation in adenomas and carcinomas of the ampulla of vater","volume":"3","author":"Howe","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2017.01.004_bib0060","series-title":"WHO Classification of Tumours of the Digestive System","first-page":"279","article-title":"Tumours of the pancreas","author":"Hruban","year":"2010"},{"key":"10.1016\/j.prp.2017.01.004_bib0065","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S1470-2045(14)70023-3","article-title":"Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study","volume":"15","author":"Iveson","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2017.01.004_bib0070","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.prp.2017.01.004_bib0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1349-7006.1994.tb02077.x","article-title":"Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater","volume":"85","author":"Kimura","year":"1994","journal-title":"Jpn. J. Cancer Res.: Gann"},{"key":"10.1016\/j.prp.2017.01.004_bib0080","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1309\/AJCPCTCUQSYI89YT","article-title":"Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications","volume":"135","author":"Kohler","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2017.01.004_bib0085","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MPA.0000000000000280","article-title":"Low frequency of KRAS mutation in pancreatic ductal adenocarcinomas in Korean patients and its prognostic value","volume":"44","author":"Kwon","year":"2015","journal-title":"Pancreas"},{"key":"10.1016\/j.prp.2017.01.004_bib0090","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.humpath.2014.03.003","article-title":"Frequent hepatocyte growth factor overexpression and low frequency of c-Met gene amplification in human papillomavirus-negative tonsillar squamous cell carcinoma and their prognostic significances","volume":"45","author":"Kwon","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2017.01.004_bib0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.humpath.2015.11.009","article-title":"Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value","volume":"50","author":"Kwon","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2017.01.004_bib0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/ijd.12664","article-title":"HIPK2 expression in progression of cutaneous epithelial neoplasm","volume":"54","author":"Kwon","year":"2015","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.prp.2017.01.004_bib0105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.prp.2014.10.006","article-title":"Comparison of HER2 gene amplification and KRAS alteration in eyelid sebaceous carcinomas with that in other eyelid tumors","volume":"211","author":"Kwon","year":"2015","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2017.01.004_bib0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.18632\/genesandcancer.96","article-title":"Prognostic impact of KRAS mutant type and MET amplification in metastatic and recurrent gastric cancer patients treated with first-line S-1 plus cisplatin chemotherapy","volume":"7","author":"Matsusaka","year":"2016","journal-title":"Genes Cancer"},{"key":"10.1016\/j.prp.2017.01.004_bib0115","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/modpathol.2013.185","article-title":"Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels","volume":"27","author":"Mikhitarian","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2017.01.004_bib0120","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/path.1779","article-title":"Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers","volume":"206","author":"Nakazawa","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2017.01.004_bib0125","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2017.01.004_bib0130","first-page":"197","article-title":"High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients","volume":"27","author":"Park","year":"2012","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.prp.2017.01.004_bib0135","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.lungcan.2015.10.022","article-title":"MET amplification, protein expression, and mutations in pulmonary adenocarcinoma","volume":"90","author":"Park","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prp.2017.01.004_bib0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0092-8674(94)90318-2","article-title":"A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor\/scatter factor receptor family","volume":"77","author":"Ponzetto","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.prp.2017.01.004_bib0145","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.510290524","article-title":"Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: a link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma","volume":"29","author":"Radaeva","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.prp.2017.01.004_bib0150","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/bjs.1800821235","article-title":"Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater","volume":"82","author":"Roder","year":"1995","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.prp.2017.01.004_bib0155","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/MPA.0b013e31823cd9df","article-title":"Frequencies and prognostic role of KRAS and BRAF mutations in patients with localized pancreatic and ampullary adenocarcinomas","volume":"41","author":"Schultz","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.prp.2017.01.004_bib0160","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1200\/JCO.2012.47.4189","article-title":"Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer","volume":"31","author":"Spigel","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2017.01.004_bib0165","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2407-8-170","article-title":"Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma","volume":"8","author":"Westgaard","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2017.01.004_bib0170","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.humpath.2015.05.012","article-title":"Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma","volume":"46","author":"Xia","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2017.01.004_bib0175","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s10620-010-1416-x","article-title":"Expression and prognostic significance of CD151, c-Met, and integrin alpha3\/alpha6 in pancreatic ductal adenocarcinomaa","volume":"56","author":"Zhu","year":"2011","journal-title":"Dig. Dis. Sci."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816302667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816302667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T21:18:17Z","timestamp":1656451097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033816302667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0344033816302667"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2017.01.004","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2017.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}